These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9457616)

  • 1. The cannabinoid receptor: computer-aided molecular modeling and docking of ligand.
    Mahmoudian M
    J Mol Graph Model; 1997 Jun; 15(3):149-53, 179. PubMed ID: 9457616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and docking of the three-dimensional structure of the human melanocortin 4 receptor.
    Yang X; Wang Z; Dong W; Ling L; Yang H; Chen R
    J Protein Chem; 2003 May; 22(4):335-44. PubMed ID: 13678297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
    Shim JY; Welsh WJ; Howlett AC
    Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel electrophilic high affinity irreversible probe for the cannabinoid receptor.
    Morse KL; Fournier DJ; Li X; Grzybowska J; Makriyannis A
    Life Sci; 1995; 56(23-24):1957-62. PubMed ID: 7776819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the third intracellular loop of the human cannabinoid 1 receptor.
    Ulfers AL; McMurry JL; Kendall DA; Mierke DF
    Biochemistry; 2002 Sep; 41(38):11344-50. PubMed ID: 12234176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand based structural studies of the CB1 cannabinoid receptor.
    Picone RP; Fournier DJ; Makriyannis A
    J Pept Res; 2002 Dec; 60(6):348-56. PubMed ID: 12464113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling.
    Fernandez LM; Puett D
    Biochemistry; 1996 Apr; 35(13):3986-93. PubMed ID: 8672431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of transmembrane helix 7 in the activation of the heptahelical lutropin receptor.
    Angelova K; Narayan P; Simon JP; Puett D
    Mol Endocrinol; 2000 Apr; 14(4):459-71. PubMed ID: 10770485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of the human vasopressin V2 receptor/agonist complex.
    Czaplewski C; Kaźmierkiewicz R; Ciarkowski J
    J Comput Aided Mol Des; 1998 May; 12(3):275-87. PubMed ID: 9749370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition.
    McAllister SD; Tao Q; Barnett-Norris J; Buehner K; Hurst DP; Guarnieri F; Reggio PH; Nowell Harmon KW; Cabral GA; Abood ME
    Biochem Pharmacol; 2002 Jun; 63(12):2121-36. PubMed ID: 12110371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-aided molecular modeling of cathepsin E, a possible endothelin-converting enzyme.
    Mahmoudian M
    J Mol Graph; 1996 Aug; 14(4):213-6, 225-6. PubMed ID: 9076635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computergraphic investigation into the pharmacological role of the THC-cannabinoid phenolic moiety.
    Semus SF; Martin BR
    Life Sci; 1990; 46(24):1781-5. PubMed ID: 2163002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor.
    Barnett-Norris J; Hurst DP; Lynch DL; Guarnieri F; Makriyannis A; Reggio PH
    J Med Chem; 2002 Aug; 45(17):3649-59. PubMed ID: 12166938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR analysis of Delta(8)-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency.
    Keimowitz AR; Martin BR; Razdan RK; Crocker PJ; Mascarella SW; Thomas BF
    J Med Chem; 2000 Jan; 43(1):59-70. PubMed ID: 10633038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3D model for the human hepatic asialoglycoprotein receptor (ASGP-R).
    Bianucci AM; Chiellini F
    J Biomol Struct Dyn; 2000 Dec; 18(3):435-51. PubMed ID: 11149519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling and docking the endothelin G-protein-coupled receptor.
    Orry AJ; Wallace BA
    Biophys J; 2000 Dec; 79(6):3083-94. PubMed ID: 11106614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A.
    Murphy JW; Kendall DA
    Biochem Pharmacol; 2003 May; 65(10):1623-31. PubMed ID: 12754098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-ligand and ligand-receptor approaches to modeling the cannabinoid CB1 and CB2 receptors: achievements and challenges.
    Reggio PH
    Curr Med Chem; 1999 Aug; 6(8):665-83. PubMed ID: 10469885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.